Commission on Medical Therapies

Reports

Annual Reports

2023: Medical Therapies Commission Annual Report

Medical Therapies - Regulatory Affairs Annual Report

2022: Medical Therapies Commission Annual Report

2021: Medical Therapies Commission Annual Report

2020: Medical Therapies Commission Annual Report

2019: Medical Therapies Commission Annual Report

2018: ILAE Annual Report | Medical Therapies Commission Annual Report

2015: Annual Report | Commission Report

2014: Annual Report | Commission Report

2013: Therapeutics Commission Report

2012: Annual Report

Publications

Vitamin D prophylaxis in persons with epilepsy? Epilepsia (2024)

Call for the use of the ILAE terminology for seizures and epilepsies by health care professionals and regulatory agencies to benefit patients and caregivers, Epilepsia (2023)

Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force, Epileptic Disorders (2022)

Barriers to Generic Antiseizure Medication Use: Results of a Global Survey by the International League Against Epilepsy Generic Substitution Task Force, Epilepsia Open (2022)

Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment, Epilepsia (2022)

Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changesEpileptic Disorders (2021)

Global Survey of Guidelines for the Management of Epilepsy in Pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy, Epilepsia Open (2020)

Managing depression and anxiety in people with epilepsy: A survey of epilepsy health professionals by the ILAE Psychology Task Force, Epilepsia Open (2020)

Use of valproate in women and girls Letter to the EMA (European Medicines Agency) from the ILAE Commission on European Affairs (CEA), ILAE Commission on Medical Therapies, and ILAE Task Force on AED Trials and Regulatory Affairs regarding PRAC recommendations to strengthen the restrictions on the use of valproate in women and girls.

Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN, 2012

Pregnancy registries: Differences, similarities, and possible harmonization, 2010

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies, 2009

Antiepileptic drugs – Best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies, 2008

Definition of Drug-Resistant Epilepsy

The Commission on Therapeutic Strategies charged a Task Force to draft a definition of Drug-Resistant Epilepsy. The resulting report was prepared in 2009 and was published in Epilepsia in 2010. (Epilepsia, 51(6):1069–1077, 2010). Read article